VISTA checkpoint inhibition by pH-selective antibody SNS-101 with optimized safety and pharmacokinetic profiles enhances PD-1 response.
Thisted T, Smith FD, Mukherjee A, Kleschenko Y, Feng F, Jiang ZG, Eitas T, Malhotra K, Biesova Z, Onumajuru A, Finley F, Cifuentes A, Zhang G, Martin GH, Takeuchi Y, Thiam K, Schreiber RD, van der Horst EH.
Thisted T, et al.
Nat Commun. 2024 Apr 4;15(1):2917. doi: 10.1038/s41467-024-47256-x.
Nat Commun. 2024.
PMID: 38575562
Free PMC article.